Ginsenoside Rb1 prevents age-related endothelial senescence by modulating SIRT1/caveolin-1/enos signaling pathway

Area of Science:

• Cardiovascular Pharmacology
• Gerontology
• Molecular Biology

Background:

• Aging is a major risk factor for cardiovascular diseases.
• Ginseng, a traditional Chinese medicine, is known for its health benefits.
• Ginsenoside Rb1 (g-Rb1), a key compound from Panax ginseng, shows potential anti-senescence properties.

Purpose of the Study:

• To investigate the precise mechanisms by which g-Rb1 influences the SIRT1/eNOS pathway.
• To explore the vascular pharmacological activity of g-Rb1 in preventing endothelial senescence.

Main Methods:

• Human primary umbilical vein endothelial cells (HUVECs) were used to model replicative aging.
• Techniques included RT-PCR, western blotting, siRNA, and immunoprecipitation.
• The study focused on the impact of g-Rb1 on the SIRT1/caveolin-1/eNOS signaling axis.

Main Results:

• G-Rb1 increased nitric oxide (NO) production and reduced endothelial cell senescence.
• g-Rb1 elevated SIRT1 and eNOS expression while decreasing caveolin-1.
• Modulation of SIRT1, eNOS, and caveolin-1 by g-Rb1 affected cellular senescence and NO production.

Conclusions:

• Ginsenoside Rb1 (g-Rb1) effectively prevents age-related endothelial senescence.
• This protective effect is mediated through the modulation of the SIRT1/caveolin-1/eNOS signaling pathway.
• g-Rb1 demonstrates potential for clinical application in managing vascular aging.